4-chloro-7-[1-(5-chloropyrimidin-2-yl)piperidin-4-yl]-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine | 1236284-73-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并嘧啶类
• 英文名称: 4-chloro-7-[1-(5-chloropyrimidin-2-yl)piperidin-4-yl]-5-fluoro-7H-pyrrolo[2,3-d]pyrimidine
• 英文别名: 4-Chloro-7-[1-(5-chloropyrimidin-2-yl)piperidin-4-yl]-5-fluoropyrrolo[2,3-d]pyrimidine
• CAS: 1236284-73-3
• 化学式: C₁₅H₁₃Cl₂FN₆
• 分子量: 367.213
• InChiKey: HMDSAUFDWTWTHU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  59.7
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• NOVEL PYRROLOÝ2,3-d¨PYRIMIDINE COMPOUND
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP2390254A1

  公开（公告）日：2011-11-30

  Disclosed is a novel pyrrolo[2,3-d]pyrimidine compound represented by formula [I] or a pharmacologically acceptable salt thereof, which has a GPR119 receptor agonistic activity and is useful for a pharmaceutical. In formula [I], E represents a group represented by formula: -NH-, or the like; ring A represents a 6-membered aromatic ring which may contain 1 to 2 nitrogen atoms as heteroatoms (the aromatic ring may be substituted by a halogen atom, a group represented by formula: -CONRaRb, or the like; Ra and Rb are the same or different and independently represent hydrogen, alkyl, hydroxyalkyl, or the like); R1 represents an acyl group or the like; and R2 represents a halogen atom or a cyano group.

  揭示了一种新型吡咯并[2,3-d]嘧啶化合物，其表示为式[I]或其药理学上可接受的盐，具有GPR119受体激动活性，并且对制药有用。在式[I]中，E代表由式表示的基团：-NH-，或类似基团；环A代表可能含有1至2个氮原子作为杂原子的6元芳香环（芳香环可能被卤素原子、由式表示的基团：-CONRaRb，或类似基团取代；Ra和Rb相同或不同且独立地代表氢、烷基、羟基烷基，或类似基团）；R1代表酰基团或类似基团；R2代表卤素原子或氰基。
• NOVEL PYRROLO(2,3-d)PYRIMIDINE COMPOUND
  申请人：Tsuboi Yasunori

  公开号：US20120016119A1

  公开（公告）日：2012-01-19

  Disclosed is a novel pyrrolo[2,3-d]pyrimidine compound represented by formula [I] or a pharmacologically acceptable salt thereof, which has a GPR119 receptor agonistic activity and is useful for a pharmaceutical. In formula [I], E represents a group represented by formula: —NH—, or the like; ring A represents a 6-membered aromatic ring which may contain 1 to 2 nitrogen atoms as heteroatoms (the aromatic ring may be substituted by a halogen atom, a group represented by formula: —CONR a R b , or the like; R a and R b are the same or different and independently represent hydrogen, alkyl, hydroxyalkyl, or the like); R 1 represents an acyl group or the like; and R 2 represents a halogen atom or a cyano group.

  本发明公开了一种新型吡咯并[2,3-d]嘧啶化合物，其化学式为[I]或其药学上可接受的盐，具有GPR119受体激动活性，可用于制药。在式[I]中，E代表化学式表示的基团：—NH—或类似基团；环A代表一个6元芳环，其中可含有1至2个氮原子作为杂原子（芳环可被卤素原子、化学式表示的基团：—CONRaRb或类似基团取代；Ra和Rb相同或不同且独立地代表氢、烷基、羟基烷基或类似基团）；R1代表酰基基团或类似基团；R2代表卤素原子或氰基。
• VASCULAR EMBOLIC FILTER EXCHANGE DEVICES AND METHODS OF USE THEREOF
  申请人：Salahieh Amr

  公开号：US20110257678A1

  公开（公告）日：2011-10-20

  Vascular embolic filtering systems, as well as methods for using the same, are provided. In general, the subject invention includes a system comprised of a delivery and retrieval sheath adapted for delivering and retrieving multiple embolic filters, wherein the embolic filters are each operatively coupled to a distal region of a filter wire segment and are deployable within a target vessel.